Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
Filters
Refine your search
Neuromodulator suitable for pharmaceutical
applications. Shelf life: 2 years.
TDS
API developed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
API designed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
HEC Pharm
HEC Pharm Co., Ltd was established in 2003. It has passed US FDA and EUGMP inspections for many times. The main products are erythromycin thiocyanate, lincomycin, erythromycin base, azithromycin dihydrate and clarithromycin. HEC is the largest manufacturer of erythromycin thiocyanate in the world
Chendga Pharmaceuticals
Chengda Pharmaceuticals Co., LTD. was set up in 1999, located in the beautiful scenery of the Hangzhou-Jiaxing-Huzhou plain.
Our company mainly produces APIs, food addictives, feed addictives, antibiotics, anticancer, antiviral of pharmaceutical intermediates, and etc,
sold in more than 30 countries and regions.
We are the largest Asian bulk pharmaceutical enterprises specializing in producing and exporting Carnitine range.
Our facilities have passed the US FDA on-site inspection.
Zhuhai United Laboratories
Founded in Hong Kong in 1990, The United Laboratories(TUL) is operating for over two decades, now TUL is positioned as one of the largest antibiotic pharmaceutical companies in the world. Considering that 100% of its capital is owned by Hong Kong Shareholders, TUL is currently structured into three Divisions: API and Intermediate Production, Biopharmaceutical products, Production formulation.
